All News

Manufacturers of timed-release guaifenesin products that have not been FDA approved have 90 days to stop making the products and 180 days to cease shipping them.

According to PhRMA, there are currently 277 medications either in clinical trials or under review by the FDA for treating heart disease and stroke, the two leading causes of death in the U.S.

CMS is now soliciting bids for the first round of the Medicare Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS) Competitive Bidding Program.

AstraZeneca is promoting its AZ&Me Rx savings program. The program helps people with imited incomes who are enrolled in a Medicare drug plan but are having difficulty affording their medicines.

More than a week after the initial deadline for registering for a National Provider Identifier (NPI) number passed, CMS released a dissemination notice that reveals that a key NPI database will be available soon.

CMS has offered detailed guidelines on how it will handle pharmacy reimbursement for vaccines under Medicare Part D.

Changes have been made to the prescribing information for deferasirox (Exjade, Novartis) following postmarketing reports of acute renal failure and cytopenias, including agranulocytosis, neutropenia, and thrombocytopenia.

The Consumer Healthcare Products Association (CHPA) applauded recent actions taken by many major retailers to prevent children under age 18 from purchasing OTC cough medicines that contain dextromethorphan.

The FDA said it will wait to further evaluate data submitted by manufacturer GlaxoSmithKline regarding the safety of its diabetes drug rosiglitazone (Avandia).

You'll be seeing a lot of the term downstream entity. That's the handle CMS proposes to use to signify pharmacies or pharmacists who contract with PBMs, dubbed first-tier entities, that, in turn, contract with Part D plan sponsors.

New immunosuppressive regimens that combine Certican and low-dose Neoral to preverse renal function following heart transplants and Viagra to lower pulmonary arterial heypertension are coming soon to hospitals.

The FDA is weighing whether to allow a system for electronic insert information for most prescription drugs, replacing paper Rx inserts.

New over the counter items with unique formulations

As the largest community specialty network in the country, Community Specialty Pharmacy Network is designed to provide a distrbution channel for specialty medications.

Some state legislatures move to increase Medicaid dispensing fees in preparation for the implementation of the new Medicaid AMP rule

Updated studies show that the greater use of life-enhancing highly active antiretroviral therapy, the more reports proliferate of unusal side effects, including lipodystrophy, lactic acidosis, insulin resistance, and recently, male osteoporosis.

Patient care must come first as the pharmacy community works toward implementation of NPI numbers.

Thomas Blischok, IRI tellls FMI Supermarket pharmacy conference attendees that there are many growth opportunities ahead if they reposition the store and tie pharmacy to the entire store.

Chronically underfunded, these agencies struggle to meet their responsibilities while fighting state and federal groups for control.

On the heels of oversight hearings on the first anniversary of the Medicare Part D program, patient advocates and pharmacists shared their insights.

The FDA approved a new treatment to help cure bacterial conjunctivitis, or pink eye, with the approval of azithromycin ophthalmic solution 1% (AzaSite) from Inspire Pharmaceuticals.

FDA has approved Neupro patch designed to treat symptoms of early Parkinson's disease. Consistent and continuous drug delivery over a 24-hour period may prove to be an advantage of this patch.

The emergence of any vaccine is a complicated event, necessitating physician, pharmacist, and public education and the creation of formulary protocols. But when a drug directly involves issues surrounding the sexual activity of underage girls, complexity devolves into controversy.

Women have more birth control choices than ever before. Oral contraceptives are vastly different from the pills that hit the market 40 years ago. New forms of contraception such as Plan B are gaining in popularity.

For decades, hormone replacement therapy (HRT) ws considere the answer not only to hot flashes but to a woman's long-term health. In July 2002, millions of women abruptly discontinued HRT.

Glatiramer is indicated for the reduction of the frequency of relapses in ambulatory patients with relapsing-remitting multiple sclerosis and is administered as a subcutaneous injection once daily.

These sites provide New Yorkers with convenient access to high-quality, urgent and nonemergency medical services at affordable prices, with the option to see on-site physicians on a walk-in basis for immediate examination and treatment.

Aetna announced the launch of a program that waives co-pays for six months.